Skip to main content
. Author manuscript; available in PMC: 2009 Jun 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2008 Jun;17(6):1344–1353. doi: 10.1158/1055-9965.EPI-07-0747

Table 1.

Baseline characteristics of participants in the PPT-based cohort by adenoma recurrence

Characteristic

Overall
No recurrence
Advanced recurrence*
Any recurrence
Mean (SD) Mean (SD) Mean (SD) P Mean (SD) P
Sample size 1,905 1,151 125 125/1,151 754 754/11,51
Age, y 61.1 (9.9) 59.9 (10.1) 65.2 (9.2) <0.0001 62.8 (9.2) <0.0001
Body mass index (kg/m2) 27.6 (3.9) 27.4 (4.0) 28.0 (4.1) 0.10 27.8 (3.9) 0.05
Gender (% male) 64 60 70 0.02 72 <0.0001
Race (% Caucasian) 90 90 90 0.99 90 0.97
Education (% ≤high school) 25 24 28 0.35 26 0.49
NSAID use (% yes) 34 35 24 0.01 31 0.11
Aspirin use (% yes) 23 23 19 0.28 22 0.55
Multivitamin use (% yes) 34 35 31 0.34 32 0.18
Vitamin A use (% yes) 33 35 30 0.24 31 0.10
Vitamin E use (% yes) 41 42 38 0.43 40 0.45
Energy intake (MJ/d) 8.05 (2.44) 7.97 (2.36) 7.93 (2.65) 0.86 8.16 (2.55) 0.11
Fruit intake (g/d) 156 (122) 152 (115) 166 (126) 0.19 162 (127) 0.07
Vegetable intake (g/d) 270 (132) 268 (125) 256 (108) 0.25 273 (120) 0.43
Family history of CRC (% yes) 27 27 26 0.96 27 0.77

NOTE: Results are presented as means (SD) for continuous variables and % for categorical variables with P values for differences in means determined by t tests and differences in proportions determined by χ2 tests. Adenomatous polyp recurrence and advanced adenoma recurrence were diagnosed using full colonoscopy at the end of year 4.

*

Comparison between the advanced adenoma recurrence group to the no adenoma recurrence group.

Comparison between the any adenoma recurrence group to the no adenoma recurrence group.